Stay updated with breaking news from Data Presented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
—Data Presented at CTAD Conference Shows that AlzoSure® Predict Can Accurately Identify Stage of Cognitive Decline and Predict Whether Individuals Will...
NE3107-treated patients experienced greater motor control in Parkinson’s trial Patients treated with the combination of NE3107 and levodopa saw...
Treatment with Aficamten Associated with Significant Improvements in Symptoms and Quality of Life Additional Data Presented in Poster Session Shows...
88% overall response rate (15 out of 17) from interim data of pan-FGFR treatment (FGFRi)-naïve FGFR2-fusion cholangiocarcinoma (CCA) patients treated
Improving cancer outcomes via improved prevention and early detection and treatment, and better educating oncologists to implement the latest discoveries, will be the focus of the ESMO Congress 2022.